Join
Live feed
·
PRReleasevia Quantisnow
Applied Therapeutics Inc. logo

Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency

ByQuantisnow·Wall Street's wire, on your screen.
APLT· Applied Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APLT (Applied Therapeutics Inc.) and more on Quantisnow.